China Seeks to Shut Down Contaminated Drug Capsule Makers
China’s State Food and Drug Administration told its provincial units to shut down plants making drug capsules containing excessive levels of chromium.
The administration has found 23 batches of tainted products from nine capsule makers including Tonghua Golden-Horse Pharmaceutical Industry Co. (000766), the SFDA said today in a statement.
The government ordered the companies to recall and destroy the affected batches of capsules. The producers must stop all drug-capsule output and sales until they are authorized to resume after inspections, according to the statement.
China’s police have detained 53 suspects and closed 10 industrial gelatin and gel capsule manufacturing plants that may be involved in the scandal, Xinhua News Agency reported today, citing the Ministry of Public Security.
To contact Bloomberg News staff for this story: Feifei Shen in Beijing at +86-10-6649-7528 or fshen11@bloomberg.net
To contact the reporter on this story: Feifei Shen in Beijing at fshen11@bloomberg.net
To contact the editor responsible for this story: Joshua Fellman at jfellman@bloomberg.net
Rate this Page
Bloomberg moderates all comments. Comments that are abusive or off-topic will not be posted to the site. Excessively long comments may be moderated as well. Bloomberg cannot facilitate requests to remove comments or explain individual moderation decisions.